Lomustine is a nitrosourea compound used as an active pharmaceutical ingredient in the manufacture of anticancer medications. It has been identified as a carcinogen and developmental toxicant based on expert review and government labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 13010-47-4
1-NO-1(2CLET)-3(4-OH CYHEXYL)UREA
pharmaceutical raw material
4-Hydroxylomustine
pharmaceutical raw material
Prezatide copper acetate
pharmaceutical raw material
Cetrorelix acetate
pharmaceutical raw material
Risperidone Pyrimidinone-N-oxide
pharmaceutical raw material
Latanoprost
pharmaceutical raw material
The international HS code for Lomustine (CAS 13010-47-4) is 2929.90.
2929.90
2929 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
GQYIWUVLTXOXAJ-UHFFFAOYSA-N
C1CCC(CC1)NC(=O)N(CCCl)N=O